GammaDelta Therapeutics Ltd - Company Review
GammaDelta Therapeutics Ltd - Company ReviewSummary
GammaDelta Therapeutics Ltd (GammaDelta Therapeutics) is a immunotherapy company which develops improved immunotherapies for cancer and other immune related diseases. The company conducts research and development focused on exploiting tissue resident gamma delta T cells, which are conserved population of lymphocytes that contribute to many types of immune responses and immunopathology. GammaDelta Therapeutics works in partnership with oncology and immune therapy research institutions which include Abingworth LLP, Kings College London, The Francis Crick Institute, Takeda Pharmaceutical and Cancer Research Technology. The company has offices and laboratories located in London BioScience Innovation Centre. GammaDelta Therapeutics is headquartered in London, England, the UK.
This comprehensive company report of GammaDelta Therapeutics Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.